Stroke

Featured Article

Weighing Benefits and Risks of Anticoagulation in the Elderly

Weighing Benefits and Risks of Anticoagulation in the Elderly

Determining which patients who have atrial fibrillation should receive anticoagulation therapy for stroke prophylaxis can be challenging.

Latest Features

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

VIDEO: AHA - Improving Patient Care in Stroke

VIDEO: AHA - Improving Patient Care in Stroke

AHA presents Laurie Paletz, stroke coordinator at Cedar-Sinai Medical Center in Los Angeles, describing her institution's experience using Get With the Guidelines-Stroke and Target: Stroke to improve patient care.

Transient Ischemic Attack Treatment Strategy Changes May Have Led to Lower CV Events Risk

Transient Ischemic Attack Treatment Strategy Changes May Have Led to Lower CV Events Risk

Risk for stroke and other vascular events at 90 days was 3.7% vs 12% to 20% in previous cohorts.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Risk and prevalence of stroke in patients with undiagnosed asymptomatic atrial fibrillation remains problematic for patients and clinicians.

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for hypertension management during acute stroke are based on clinician experience.

Latest News

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.

Does Insomnia Increase Risk of CV and Stroke Events?

Does Insomnia Increase Risk of CV and Stroke Events?

The study analysis focused on the link between cardio-cerebral vascular events and difficulty initiating and maintaining sleep, among others.

History of Migraine Linked to Ischemic Stroke Via Cervical Artery Dissection

History of Migraine Linked to Ischemic Stroke Via Cervical Artery Dissection

Researchers examined a sample of 2485 patients who had early-onset ischemic stroke.

Prevalence of Inadequate Therapeutic Anticoagulation for Afib Preceding Ischemic Stroke Examined

Prevalence of Inadequate Therapeutic Anticoagulation for Afib Preceding Ischemic Stroke Examined

Inadequate therapeutic anticoagulation prior to the occurrence of ischemic stroke was found to be prevalent.

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

A decline in function status occurred an average of 2 years before hospitalization for myocardial infarction, and 3 years before heart failure and stroke.

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.

Acute Coronary Syndrome Risk Reduced With Pioglitazone in Insulin Resistance Post-Stroke

Acute Coronary Syndrome Risk Reduced With Pioglitazone in Insulin Resistance Post-Stroke

Pioglitazone reduced the risk of acute coronary syndromes, including type 1 myocardial infarction.

Prestroke CHA2DS2-VASc Predictive of Stroke Severity, Mortality

Prestroke CHA2DS2-VASc Predictive of Stroke Severity, Mortality

The relationship between prestroke CHA2DS2-VASc score and stroke severity and functional outcome in patients with AF and acute ischemic stroke was evaluated.

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

Compared with warfarin, there were lower rates of stroke with dabigatran 110 mg and 150 mg twice daily.

Cilostazol Efficacy for Secondary Stroke Prevention in Ischemic Stroke

Cilostazol Efficacy for Secondary Stroke Prevention in Ischemic Stroke

Cardiovascular risks should be considered prior to initiating cilostazol therapy in patients with ischemic stroke.

Sign Up for Free e-Newsletters